ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,000 | – | 1,800 | +592.3% | 0.00% | – |
Q3 2016 | $0 | – | 260 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 260 | -74.0% | 0.00% | – |
Q1 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $2,000 | +100.0% | 1,000 | +609.2% | 0.00% | – |
Q2 2015 | $1,000 | -93.3% | 141 | -94.4% | 0.00% | -100.0% |
Q2 2014 | $15,000 | -80.8% | 2,500 | -79.8% | 0.00% | -66.7% |
Q1 2014 | $78,000 | +1014.3% | 12,400 | +933.3% | 0.01% | +500.0% |
Q4 2013 | $7,000 | +40.0% | 1,200 | +20.0% | 0.00% | 0.0% |
Q3 2013 | $5,000 | -37.5% | 1,000 | 0.0% | 0.00% | -50.0% |
Q2 2013 | $8,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |